1. Reversing immunosenescence for prevention of COVID-19.
32597792
PMC7320258 2. Could the COVID-19 pandemic aggravate antimicrobial resistance?
32603851
PMC7302068 3. Hypotension, SIRS and COVID-19: a clinical conundrum.
32541247
PMC7078746 4. Processing of the SARS-CoV pp1a/ab nsp7-10 region.
32083638
PMC7261327 5. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
32596311
PMC7284254 6. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
32553273
PMC7293470 7. Surviving the storm: Dealing with COVID-19.
32563849
PMC7311890 8. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.
32610096
PMC7232923 9. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
32424591
10. Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.
32545714
11. Cytokines and the still-baffling clinical biology of COVID-19.
32605973
PMC7319938 12. Less expression of CD4(+) and CD8(+) T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis.
32598880
PMC7306200 13. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
32579952
14. Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2.
32610037
PMC7318920 15. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
32598884
PMC7325194 16. Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.
32605661
PMC7266772 17. COVID-19 and Crimean-Congo Hemorrhagic Fever: Similarities and Differences.
32536567
PMC7276322 18. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
32561270
PMC7321048 19. Cytokine Storms: Understanding COVID-19.
32610079
PMC7295455 20. Assessing Immune Response to SARS-CoV-2 Infection.
32607314
PMC7282679 21. Update on the target structures of SARS-CoV-2: A systematic review.
32565603
22. A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.
32537960
23. Reply: COVID-19, A and Hypersensitivity Pneumonitis.
32537959
PMC7293471 24. The role of extracellular vesicles in COVID-19 virus infection.
32544615
PMC7319641 25. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
32599245
PMC7293840 26. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
32553716
PMC7312818 27. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
32481719
PMC7279029 28. AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?
32429235
29. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
32604730
30. Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.
32604724
31. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
32534506
PMC7282741 32. Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.
32592996
PMC7296326 33. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
32563547
34. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
32587094
35. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2).
32571880
PMC7320913 36. Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19.
32594342
37. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review.
32605192
38. Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes.
32549229
PMC7301648 39. The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
32556101
PMC7275996 40. Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient.
32591314
PMC7308036 41. Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis.
32585161
PMC7306202 42. The lung tissue microbiota features of 20 deceased patients with COVID-19.
32579991
PMC7305716 43. CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.
32569604
PMC7290187 44. Elevated nucleoprotein-induced interferon-gamma release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.
32540458
PMC7194903 45. Re: Profile of specific antibodies to SARS-CoV-2: The first report.
32283140
PMC7275988 46. Persistence of SARS-CoV-2 virus RNA in feces: A case series of children.
32546439
PMC7320995 47. Hypercytokinemia and Pathogen-Host Interaction in COVID-19.
32606886
PMC7323341 48. Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.
32558957
PMC7323243 49. Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line.
32558946
PMC7323247 50. Dysregulation of the immune response affects the outcome of critical COVID-19 patients.
32543740
PMC7293762 51. Characteristics, Cardiac involvement, and Outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) Associated with SARS-CoV-2 Infection.
32553873
PMC7293760 52. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City.
32553861
PMC7291990 53. Coronavirus disease 2019, Kawasaki disease, and multisystem inflammatory syndrome in children.
32540255
PMC6613758 54. Identification and Characterization of a Human Coronavirus 229E Nonstructural Protein 8-Associated RNA 3'-Terminal Adenylyltransferase Activity.
30918070
PMC6532078 55. The Infectious Bronchitis Coronavirus Envelope Protein Alters Golgi pH To Protect the Spike Protein and Promote the Release of Infectious Virus.
30867314
PMC7323185 56. Hypermetabolism and COVID-19.
32559309
57. Hyperinflammation hos barn kan ha samband med covid-19.
32542615
PMC7252431 58. Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?
32540605
PMC7289107 59. Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19.
32562912
PMC7322708 60. The cholinergic anti-inflammatory pathway alleviates acute lung injury.
32600316
PMC7242205 61. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.
32537478
PMC7293838 62. Phyloevolutionary analysis of SARS-CoV-2 in Nigeria.
32566234
PMC7290170 63. Perspective on oral exfoliative cytology and COVID-19.
32561129
PMC7278893 64. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.
32547891
PMC7268134 65. Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?
32537129
PMC7291997 66. Can the microcirculatory response to hypoxia be a prognostic factor for Covid-19?
32540481
PMC7266759 67. Tratamiento y evolucion del sindrome de tormenta de citoquinas asociados a infeccion por SARS-CoV-2 en pacientes octogenarios.
32564984
PMC7315691 68. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
32588191
PMC7299625 69. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
32596474
PMC7319493 70. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
32591408
PMC7317891 71. Door to the cell for COVID-19 opened, leading way to therapies.
32591496
PMC7303571 72. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
32561706
PMC7298436 73. Targeting the entry step of SARS-CoV-2: a promising therapeutic approach.
32555145
74. Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period.
32580215
PMC7298425 75. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.
32539627
76. Kronisk inflammatorisk tarmsykdom og covid-19.
32378846
PMC7260555 77. In Vitro and Animal Models for SARS-CoV-2 research.
32553545
PMC7305739 78. Deciphering the TCR Repertoire to Solve the COVID-19 Mystery.
32576386
PMC7314510 79. Gut-lung axis and dysbiosis in COVID-19.
32595361
PMC7314506 80. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.
32595356
PMC7314507 81. Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey.
32595354
PMC7314513 82. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks.
32595353
PMC7314508 83. An updated analysis of variations in SARS-CoV-2 genome.
32595352
PMC7314511 84. Phylogenetic analysis of SARS-CoV-2 genomes in Turkey.
32595351
PMC7311156 85. Lung Pathology in COVID-19 Disease: We Must Be Aware!
32584242
PMC7303940 86. Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell.
32562199
PMC7309931 87. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
32589897
88. A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19.
32549200
{{tp|p=32597792|t=2020. Reversing immunosenescence for prevention of COVID-19.|pdf=|usr=}}
{{tp|p=32603851|t=2020. Could the COVID-19 pandemic aggravate antimicrobial resistance?|pdf=|usr=}}
{{tp|p=32541247|t=2020. Hypotension, SIRS and COVID-19: a clinical conundrum.|pdf=|usr=}}
{{tp|p=32083638|t=2020. Processing of the SARS-CoV pp1a/ab nsp7-10 region.|pdf=|usr=}}
{{tp|p=32596311|t=2020. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?|pdf=|usr=}}
{{tp|p=32553273|t=2020. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.|pdf=|usr=}}
{{tp|p=32563849|t=2020. Surviving the storm: Dealing with COVID-19.|pdf=|usr=}}
{{tp|p=32610096|t=2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.|pdf=|usr=}}
{{tp|p=32424591|t=2020. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?|pdf=|usr=}}
{{tp|p=32545714|t=2020. Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.|pdf=|usr=}}
{{tp|p=32605973|t=2020. Cytokines and the still-baffling clinical biology of COVID-19.|pdf=|usr=}}
{{tp|p=32598880|t=2020. Less expression of CD4(+) and CD8(+) T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis.|pdf=|usr=}}
{{tp|p=32579952|t=2020. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?|pdf=|usr=}}
{{tp|p=32610037|t=2020. Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=}}
{{tp|p=32598884|t=2020. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.|pdf=|usr=}}
{{tp|p=32605661|t=2020. Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.|pdf=|usr=}}
{{tp|p=32536567|t=2020. COVID-19 and Crimean-Congo Hemorrhagic Fever: Similarities and Differences.|pdf=|usr=}}
{{tp|p=32561270|t=2020. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.|pdf=|usr=}}
{{tp|p=32610079|t=2020. Cytokine Storms: Understanding COVID-19.|pdf=|usr=}}
{{tp|p=32607314|t=2020. Assessing Immune Response to SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32565603|t=2020. Update on the target structures of SARS-CoV-2: A systematic review.|pdf=|usr=}}
{{tp|p=32537960|t=2020. A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.|pdf=|usr=}}
{{tp|p=32537959|t=2020. Reply: COVID-19, A and Hypersensitivity Pneumonitis.|pdf=|usr=}}
{{tp|p=32544615|t=2020. The role of extracellular vesicles in COVID-19 virus infection.|pdf=|usr=}}
{{tp|p=32599245|t=2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.|pdf=|usr=}}
{{tp|p=32553716|t=2020. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.|pdf=|usr=}}
{{tp|p=32481719|t=2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.|pdf=|usr=}}
{{tp|p=32429235|t=2020. AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?|pdf=|usr=}}
{{tp|p=32604730|t=2020. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.|pdf=|usr=}}
{{tp|p=32604724|t=2020. Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.|pdf=|usr=}}
{{tp|p=32534506|t=2020. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?|pdf=|usr=}}
{{tp|p=32592996|t=2020. Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.|pdf=|usr=}}
{{tp|p=32563547|t=2020. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.|pdf=|usr=}}
{{tp|p=32587094|t=2020. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.|pdf=|usr=}}
{{tp|p=32571880|t=2020. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2).|pdf=|usr=}}
{{tp|p=32594342|t=2020. Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19.|pdf=|usr=}}
{{tp|p=32605192|t=2020. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review.|pdf=|usr=}}
{{tp|p=32549229|t=2020. Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes.|pdf=|usr=}}
{{tp|p=32556101|t=2020. The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.|pdf=|usr=}}
{{tp|p=32591314|t=2020. Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient.|pdf=|usr=}}
{{tp|p=32585161|t=2020. Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis.|pdf=|usr=}}
{{tp|p=32579991|t=2020. The lung tissue microbiota features of 20 deceased patients with COVID-19.|pdf=|usr=}}
{{tp|p=32569604|t=2020. CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.|pdf=|usr=}}
{{tp|p=32540458|t=2020. Elevated nucleoprotein-induced interferon-gamma release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.|pdf=|usr=}}
{{tp|p=32283140|t=2020. Re: Profile of specific antibodies to SARS-CoV-2: The first report.|pdf=|usr=}}
{{tp|p=32546439|t=2020. Persistence of SARS-CoV-2 virus RNA in feces: A case series of children.|pdf=|usr=}}
{{tp|p=32606886|t=2020. Hypercytokinemia and Pathogen-Host Interaction in COVID-19.|pdf=|usr=}}
{{tp|p=32558957|t=2020. Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.|pdf=|usr=}}
{{tp|p=32558946|t=2020. Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line.|pdf=|usr=}}
{{tp|p=32543740|t=2020. Dysregulation of the immune response affects the outcome of critical COVID-19 patients.|pdf=|usr=}}
{{tp|p=32553873|t=2020. Characteristics, Cardiac involvement, and Outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) Associated with SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32553861|t=2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City.|pdf=|usr=}}
{{tp|p=32540255|t=2020. Coronavirus disease 2019, Kawasaki disease, and multisystem inflammatory syndrome in children.|pdf=|usr=}}
{{tp|p=30918070|t=2019. Identification and Characterization of a Human Coronavirus 229E Nonstructural Protein 8-Associated RNA 3'-Terminal Adenylyltransferase Activity.|pdf=|usr=}}
{{tp|p=30867314|t=2019. The Infectious Bronchitis Coronavirus Envelope Protein Alters Golgi pH To Protect the Spike Protein and Promote the Release of Infectious Virus.|pdf=|usr=}}
{{tp|p=32559309|t=2020. Hypermetabolism and COVID-19.|pdf=|usr=}}
{{tp|p=32542615|t=2020. Hyperinflammation hos barn kan ha samband med covid-19.|pdf=|usr=}}
{{tp|p=32540605|t=2020. Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?|pdf=|usr=}}
{{tp|p=32562912|t=2020. Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19.|pdf=|usr=}}
{{tp|p=32600316|t=2020. The cholinergic anti-inflammatory pathway alleviates acute lung injury.|pdf=|usr=}}
{{tp|p=32537478|t=2020. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.|pdf=|usr=}}
{{tp|p=32566234|t=2020. Phyloevolutionary analysis of SARS-CoV-2 in Nigeria.|pdf=|usr=}}
{{tp|p=32561129|t=2020. Perspective on oral exfoliative cytology and COVID-19.|pdf=|usr=}}
{{tp|p=32547891|t=2020. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32537129|t=2020. Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?|pdf=|usr=}}
{{tp|p=32540481|t=2020. Can the microcirculatory response to hypoxia be a prognostic factor for Covid-19?|pdf=|usr=}}
{{tp|p=32564984|t=2020. Tratamiento y evolucion del sindrome de tormenta de citoquinas asociados a infeccion por SARS-CoV-2 en pacientes octogenarios.|pdf=|usr=}}
{{tp|p=32588191|t=2020. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32596474|t=2020. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32591408|t=2020. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.|pdf=|usr=}}
{{tp|p=32591496|t=2020. Door to the cell for COVID-19 opened, leading way to therapies.|pdf=|usr=}}
{{tp|p=32561706|t=2020. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.|pdf=|usr=}}
{{tp|p=32555145|t=2020. Targeting the entry step of SARS-CoV-2: a promising therapeutic approach.|pdf=|usr=}}
{{tp|p=32580215|t=2020. Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period.|pdf=|usr=}}
{{tp|p=32539627|t=2020. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.|pdf=|usr=}}
{{tp|p=32378846|t=2020. Kronisk inflammatorisk tarmsykdom og covid-19.|pdf=|usr=}}
{{tp|p=32553545|t=2020. In Vitro and Animal Models for SARS-CoV-2 research.|pdf=|usr=}}
{{tp|p=32576386|t=2020. Deciphering the TCR Repertoire to Solve the COVID-19 Mystery.|pdf=|usr=}}
{{tp|p=32595361|t=2020. Gut-lung axis and dysbiosis in COVID-19.|pdf=|usr=}}
{{tp|p=32595356|t=2020. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.|pdf=|usr=}}
{{tp|p=32595354|t=2020. Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey.|pdf=|usr=}}
{{tp|p=32595353|t=2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks.|pdf=|usr=}}
{{tp|p=32595352|t=2020. An updated analysis of variations in SARS-CoV-2 genome.|pdf=|usr=}}
{{tp|p=32595351|t=2020. Phylogenetic analysis of SARS-CoV-2 genomes in Turkey.|pdf=|usr=}}
{{tp|p=32584242|t=2020. Lung Pathology in COVID-19 Disease: We Must Be Aware!|pdf=|usr=}}
{{tp|p=32562199|t=2020. Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell.|pdf=|usr=}}
{{tp|p=32589897|t=2020. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.|pdf=|usr=}}
{{tp|p=32549200|t=2020. A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19.|pdf=|usr=}}
89. Cytokine Storm in COVID19: A Neural Hypothesis.
32605374
90. Reliable Postmortem Computed Tomography Scan Diagnosis of COVID-19 Pneumonia.
32604146
91. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
32584597
92. Radiology-pathology Correlation in Recovered COVID-19, Demonstrating Organizing Pneumonia.
32609531
93. Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.
32581017
94. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.
32602262
95. CoViD-19 epidemic follows the "kinetics" of enzymes with cooperative substrate binding.
32604468
96. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome.
32597954
97. Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.
32609845
98. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
32594085
99. Herd immunity or suppression strategy to combat COVID-19.
32538831
100. COVID-19 and the endothelium.
32568187
101. The compelling arguments for the need of microvascular investigation in COVID-19 critical patients.
32568186
102. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis.
32601125
103. The cytokine storm of COVID-19: a spotlight on prevention and protection.
32594778
104. Peripheral lymphocyte subset alterations in COVID-19 patients.
32608572
105. Comparative pathogenesis of bovine and porcine respiratory coronaviruses in the animal host species and SARS-CoV-2 in humans.
32522830
106. COVID-19 autopsy in people who died in community settings: the first series.
32605920
107. Diarrhea and altered inflammatory cytokine pattern in severe COVID-19: impact on disease course and in-hospital mortality.
32602128
108. The Definition and Risks of Cytokine Release Syndrome in 11 COVID-19-Affected Critically Ill Patients with Pneumonia: Analysis of Disease Characteristics.
32601708
109. Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China.
32563194
110. Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation.
32563187
111. SARS-CoV-2: march toward adaptation.
32598499
112. The cytokine storm and COVID-19.
32592501
{{tp|p=32605374|t=2020. Cytokine Storm in COVID19: A Neural Hypothesis.|pdf=|usr=}}
{{tp|p=32604146|t=2020. Reliable Postmortem Computed Tomography Scan Diagnosis of COVID-19 Pneumonia.|pdf=|usr=}}
{{tp|p=32584597|t=2020. Characterization of the Inflammatory Response to Severe COVID-19 Illness.|pdf=|usr=}}
{{tp|p=32609531|t=2020. Radiology-pathology Correlation in Recovered COVID-19, Demonstrating Organizing Pneumonia.|pdf=|usr=}}
{{tp|p=32581017|t=2020. Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.|pdf=|usr=}}
{{tp|p=32602262|t=2020. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.|pdf=|usr=}}
{{tp|p=32604468|t=2020. CoViD-19 epidemic follows the "kinetics" of enzymes with cooperative substrate binding.|pdf=|usr=}}
{{tp|p=32597954|t=2020. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome.|pdf=|usr=}}
{{tp|p=32609845|t=2020. Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.|pdf=|usr=}}
{{tp|p=32594085|t=2020. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.|pdf=|usr=}}
{{tp|p=32538831|t=2020. Herd immunity or suppression strategy to combat COVID-19.|pdf=|usr=}}
{{tp|p=32568187|t=2020. COVID-19 and the endothelium.|pdf=|usr=}}
{{tp|p=32568186|t=2020. The compelling arguments for the need of microvascular investigation in COVID-19 critical patients.|pdf=|usr=}}
{{tp|p=32601125|t=2020. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis.|pdf=|usr=}}
{{tp|p=32594778|t=2020. The cytokine storm of COVID-19: a spotlight on prevention and protection.|pdf=|usr=}}
{{tp|p=32608572|t=2020. Peripheral lymphocyte subset alterations in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32522830|t=2020. Comparative pathogenesis of bovine and porcine respiratory coronaviruses in the animal host species and SARS-CoV-2 in humans.|pdf=|usr=}}
{{tp|p=32605920|t=2020. COVID-19 autopsy in people who died in community settings: the first series.|pdf=|usr=}}
{{tp|p=32602128|t=2020. Diarrhea and altered inflammatory cytokine pattern in severe COVID-19: impact on disease course and in-hospital mortality.|pdf=|usr=}}
{{tp|p=32601708|t=2020. The Definition and Risks of Cytokine Release Syndrome in 11 COVID-19-Affected Critically Ill Patients with Pneumonia: Analysis of Disease Characteristics.|pdf=|usr=}}
{{tp|p=32563194|t=2020. Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China.|pdf=|usr=}}
{{tp|p=32563187|t=2020. Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation.|pdf=|usr=}}
{{tp|p=32598499|t=2020. SARS-CoV-2: march toward adaptation.|pdf=|usr=}}
{{tp|p=32592501|t=2020. The cytokine storm and COVID-19.|pdf=|usr=}}